MGMT and glioblastoma: Rosas-Alonso et al. evaluated the clinical use of MGMT methylation in small extracellular vesicles (sEV)-based liquid biopsy as an instrument for glioblastoma patient management and the benefits of sEV as a predictive biomarker and disease surveillance instrument in patients with IDH-wildtype GBM.